+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats



Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats



Journal of Hepatology 28(Suppl. 1): 126




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 034144803

Download citation: RISBibTeXText

DOI: 10.1159/000056080


Related references

Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats. Pharmacology 62(2): 107-112, 2001

2-Hydroxypropyl-beta-cyclodextrin complexation with ursodeoxycholic acid. International Journal of Pharmaceutics (Amsterdam) 118(1): 77-83, 1995

Improvement of ursodeoxycholic acid bioavailability by 2-hydroxypropyl-beta-cyclodextrin complexation in healthy volunteers. Pharmacological Research 31(3-4): 205-209, 1995

Tauro-ursodeoxycholic acid vs. ursodeoxycholic acid in the dissolution of biliary calculi. Results of a single blind study. La Clinica Terapeutica 143(5): 421-428, 1993

Improved bioavailability of ursodeoxycholic acid by inclusion in 2-hydroxypropyl-beta-cyclodextrin. Journal of Hepatology 18(Suppl. 1): S167, 1993

Evidence that ursodeoxycholic acid increases biliary excretion of cholic acid and chenodeoxycholic acid in man. Gastroenterology 106(4 Suppl. ): A935, 1994

DELTA-22-ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism. Biochemistry. 34(13): 4169-4178, 1995

Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate. International Journal of Pharmaceutics 190(2): 139-153, 1999

Unsaturation of ursodeoxycholic acid in chronic ursodeoxycholic administration in rats. Gastroenterology 106(4 Suppl. ): A1018, 1994

Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial. Endoscopy 33(6): 491-494, 2001

Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. Journal of Hepatology 25(1): 49-57, 1996

Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone. Journal of Hepatology 18(1): 9-14, 1993

The effects of colchicine and methotrexate are additive to ursodeoxycholic acid for patients with primary biliary cirrhosis who respond incompletely to ursodeoxycholic acid. Hepatology 26(4 Part 2): 438A, 1997

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 24(5): 1098-1103, 1996

Therapeutic Equivalence of Ursodeoxycholic Acid Tablets and Ursodeoxycholic Acid Capsules for the Treatment of Primary Biliary Cirrhosis. Clinical Pharmacology in Drug Development 2(3): 231-236, 2013